Effects of FDA Safety Warnings May Vary

被引：2

|

作者：

Kuehn, Bridget M.

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2012年 / 307卷 / 09期

关键词：

D O I：

10.1001/jama.2012.217

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

下载

收藏

页码：894 / 895

页数：2

相关论文

共 50 条

[1] The FDA and New Safety Warnings
Moore, Thomas J.
Singh, Sonal
Furberg, Curt D.
ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (01) : 78 - 80
[2] US FDA 2009 drug safety warnings analysed
Reactions Weekly, 2012, 1388 (1) : 4 - 4
[3] FDA Safety Warnings and Trends in Testosterone Marketing to Physicians
Togun, Adeniyi
Sankar, Ashwini
Karaca-Mandic, Pinar
AMERICAN JOURNAL OF MANAGED CARE, 2022, 28 (03): : E78 - +
[4] FDA requires updated safety warnings for Janus kinase inhibitors
Reactions Weekly, 2021, 1872 (1) : 2 - 2
[5] Drug safety warnings may have unintended impact
Reactions Weekly, 2020, 1792 (1) : 4 - 4
[6] IMPACT OF FDA SAFETY WARNINGS ON SUBSEQUENT DIABETES CARE FOR USERS OF ROSIGLITAZONE
Huse, D.
Bizier, R.
VALUE IN HEALTH, 2009, 12 (07) : A402 - A403
[7] Standardized instruction - Effects may vary
Scherer, M
EDUCATIONAL LEADERSHIP, 2000, 58 (01) : 5 - 5
[8] FDA MAY PREEMPT DRUG SAFETY TESTING
不详
MATERIALS RESEARCH AND STANDARDS, 1972, 12 (08): : 34 - &
[9] Bridging the gap between FDA safety warnings and patients: are pharmacists the appropriate messengers?
Robinson, Mckay
Gunning, Karen
Pippitt, Karly
McAdam-Marx, Carrie
Jennings, Brandon T.
PHARMACOTHERAPY, 2012, 32 (10): : E266 - E267
[10] FDA orders estrogen safety warnings - Agency offers guidance for HRT use
Stephenson, J
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (05): : 537 - 538

← 1 2 3 4 5 →